Simplifying treatment of mental, neurological disorders
Friday, 08 October 2010
7 October 2010 -- Millions of people with common, but untreated, mental, neurological and substance use disorders can now benefit from new simplified diagnosis and treatment guidelines. The guidelines are designed to facilitate the management of depression, alcohol use disorders, epilepsy and other common mental disorders in the primary health-care setting.
The drinking pot: a social event that is improving health behaviour
Saturday, 02 October 2010
1 October 2010 -- Myths and misinformation abound in rural communities where people have limited access to health information. A grass-roots initiative to bring health education to the "drinking pot", or communal beer drinking ritual, is changing the way communities learn about health in Uganda. This WHO Bulletin article explains how this social event is improving health behaviours.
FDA significantly restricts access to the diabetes drug Avandia
Friday, 24 September 2010
The U.S. Food and Drug Administration today announced that it will significantly restrict the use of the diabetes drug Avandia (rosiglitazone) to patients with Type 2 diabetes who cannot control their diabetes on other medications. These new restrictions are in response to data that suggest an elevated risk of cardiovascular events, such as heart attack and stroke, in patients treated with Avandia.
Millions treated in Pakistan but challenges remain
Friday, 24 September 2010
23 September 2010 -- Nearly six million people have been treated for health conditions since the floods began in Pakistan in late July but more needs to be done to prevent future health crises or food insecurity caused by large-scale damage to crops and agricultural land. To respond to these continuing needs the Pakistan floods emergency response plan seeks US$ 200 million to fund some 94 health sector projects.
U.S. Department of Justice Press Release
Wednesday, 22 September 2010
KANSAS CITY, KAN. – A California man has pleaded guilty to creating a fraudulent marketing scheme to sell medical equipment and drug treatments for a nonexistent epidemic of Lyme disease, U.S. Attorney Barry Grissom said today.
FDA reviewing preliminary safety information on Actos (pioglitazone)
Saturday, 18 September 2010
The U.S. Food and Drug Administration today announced it has begun a safety review of the diabetes drug Actos (pioglitazone), after receiving preliminary results from a long-term observational study designed to evaluate the risk of bladder cancer associated with use of this drug.
FDA, U. of Md. train Bangladeshis on aquaculture safety
Friday, 17 September 2010
Seafood safety experts from the U.S. Food and Drug Administration and the University of Maryland Joint Institute for Food Safety and Applied Nutrition (JIFSAN) are training 10 scientists from Bangladesh on how to eliminate health hazards from aquaculture – the controlled production of seafood, much of which is exported to the United States.
People with mental disabilities cannot be forgotten
Friday, 17 September 2010
16 SEPTEMBER 2010 | NEW YORK | GENEVA -- People with mental and psychosocial disabilities are among the most marginalized groups in developing countries. Even though development actors have pledged to focus their work on the most vulnerable in a community, many programmes continue to ignore and exclude this vulnerable group.
Forest Pharmaceuticals agrees to guilty plea for violating FDA laws
Thursday, 16 September 2010
The U.S. Food and Drug Administration (FDA), working in close coordination with the U.S. Department of Justice (USDOJ), today announced that Forest Pharmaceuticals, Inc. entered into a plea agreement in which the company accepted responsibility for criminal actions including distribution of an unapproved new drug, distribution of a misbranded drug, and obstruction of an FDA inspection.
Maternal deaths worldwide drop by third
Thursday, 16 September 2010
UN estimates reveal fewer women dying from pregnancy-related causes, but 1000 still die a day and more needs to be done to achieve set targets
© Copyright 2001-2022 eDoctorOnline.com
